The trial established the IGF-1 axis as a clinical therapeutic target and supports the broader pharmacological rationale for IGF-1 receptor agonism, of which IGF-1 LR3 is one analog with extended pharmacokinetic properties
Tesamorelin is studied as a GHRH analog with relevance to pituitary-axis signaling, GH release models, IGF-1 pathway activity, and metabolic regulation
Complete the Glow with Glutanex Products
Once the fatty acids arrive inside the mitochondria, they are oxidized (burned)
There has been an ongoing debate for the last 25 years regarding the biological significance of the E-peptides, and whether or not they represent additional growth factors generated from the same Igf1 gene, or if they are simply a by-product of the post-translational processing for IGF-I
This remains the only human clinical data for a MOTS-c-based compound